A glaucoma treatment that skips the poke in the eye

By Jan Jarvis

Suchismita Web
 
One of the ways researchers are exploring treating the optic nerve damage of glaucoma is an injection directly into the eye.

But Suchismita Acharya, PhD, is studying a different approach that not only takes the pain out of treating this blinding disease but also holds the promise of curing it.

HSC Insider

Learn more about UNTHSC’s people and programs by signing up for the weekly HSC Insider email.

“Wouldn’t an eye drop be so much better?” she said. “Who likes getting poked into the eye?”

Dr. Acharya, a Research Assistant Professor in Pharmacology & Neuroscience and the North Texas Eye Research Institute, is working on a small molecule that can treat glaucoma by simultaneously decreasing eye pressure and protecting neurons and retinal ganglion cells.

“Such a compound could lower pressure in the front of the eye and also reach the back of the eye to protect ganglion cells,” she said. “This could be a cure for glaucoma.”

Her lab has designed and synthesized a unique nanosuspension eye drop of the new hybrid molecule that can reach to the back of the eye. It can easily be manufactured and used to target glaucoma, Dr. Acharya said.

By 2020, more than 76 million people are estimated to be affected by glaucoma, which is associated with elevated eye pressure and progressive death of retinal ganglion cells.

Dr. Acharya said the unique design of the drug makes it possible to both decrease intraocular pressure and prevent retinal ganglion cell death.

BrightFocus Foundation has awarded a $150,000 research grant to Dr. Acharya to further explore this approach. The Maryland-based nonprofit organization supports scientific research for Alzheimer’s disease, glaucoma and macular degeneration.

“This grant will help me expand on this research study and allow me to apply for bigger grants to help in evaluating the drug in human eyes and ultimately develop an eye drop to treat glaucoma,” Dr. Acharya said.

Recent News

Dr. Allison
  • Research
|May 20, 2022

HELP app for people of color living with HIV and HCV set to launch 

  In the face of soaring hepatitis C rates among people of color living with HIV, Dr. Wari Allison and her team set out to address the issue in a uniquely modern fashion. The vice president for health policy and director of the Center for Health Policy at The University of North Texas Healt...
Priya Bui Pediatric Doctor For Unthsc.
  • Our People
|May 16, 2022

Dr. Priya Bui named TCOM’s chair of Pediatrics and Women’s Health  

The Texas College of Osteopathic Medicine at The University of North Texas Health Science Center at Fort Worth has named Priya Bui, DO, CPPS, FAAP chair of the Department of Pediatrics and Women’s Health. Dr. Bui, a 2011 TCOM graduate who has served as interim chair since March 2021, is the first ...
Unt Health Science Center. June 7, 2019.
  • Community
|May 12, 2022

HSC Innovation Challenge grows with new partnerships 

The HSC Next Innovation Challenge is expanding to include employees in the JPS Health Network, and is partnering with Heartland Forward and Builders + Backers, national organizations that will manage and provide additional support and funding to the idea accelerator. Heartland Forward and Builder...
Justin Luningham HSC School of Public Health
  • Our People
|May 11, 2022

Using data science to assure trust and integrity in research  

“Trust” is a powerful word. In research, the reliability of data and the methods used to analyze that data can change people’s lives and have a profound impact on the world. Research scientists, especially in public health, want to know that the information they report and the conclusions t...